Skip to main content
SpringerLink
Log in

No increased risk of cancer recurrence with TNF inhibitors

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Raaschou P, et al. Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis: A Nationwide Population-Based Cohort Study. Annals of Internal Medicine : 14 Aug 2018. Available from: URL: http://dx.doi.org/10.7326/M17-2812

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

No increased risk of cancer recurrence with TNF inhibitors. Reactions Weekly 1718, 7 (2018). https://doi.org/10.1007/s40278-018-51351-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-51351-y

Search

Navigation